ADMA BIOLOGICS, INC. Operating Leases, Rent Expense
ADMA BIOLOGICS, INC. (ADMA) reported Operating Leases, Rent Expense of $300.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-05-12
- ADMA BIOLOGICS, INC. operating leases, rent expense for the quarter ending 2021-03-31 was $300.00K, a 200.00% increase year-over-year.
- ADMA BIOLOGICS, INC. operating leases, rent expense for the quarter ending 2020-09-30 was $200.00K, a 100.00% increase year-over-year.
- ADMA BIOLOGICS, INC. operating leases, rent expense for the quarter ending 2020-06-30 was $100.00K, a 99999900.00% increase year-over-year.
- ADMA BIOLOGICS, INC. operating leases, rent expense for the quarter ending 2020-03-31 was $100.00K.
- ADMA BIOLOGICS, INC. operating leases, rent expense for fiscal 2019 was $120.00K, a 0.00% change from fiscal 2018.
- ADMA BIOLOGICS, INC. operating leases, rent expense for fiscal 2018 was $120.00K, a 40.00% decline from fiscal 2017.
- ADMA BIOLOGICS, INC. operating leases, rent expense for fiscal 2017 was $200.00K, a 0.00% change from fiscal 2016.
- ADMA BIOLOGICS, INC. operating leases, rent expense for fiscal 2016 was $200.00K, a 107.37% increase from fiscal 2015.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2021-03-31 | $300.00K 10-Q · filed 2021-05-12 | ||||
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-05 | $300.00K derived: sum of 2 quarters · filed 2020-11-05 | $400.00K 10-Q · filed 2020-11-05 | $220.00K derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-06-30 | $100.00K 10-Q · filed 2020-08-05 | $200.00K 10-Q · filed 2020-08-05 | $20.00K derived: sum of 3 quarters · filed 2021-05-12 | $120.00K derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-03-31 | $100.00K 10-Q · filed 2021-05-12 | -$80.00K derived: sum of 2 quarters · filed 2021-05-12 | $20.00K derived: sum of 3 quarters · filed 2021-05-12 | $20.00K derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | -$180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$80.00K derived: sum of 2 quarters · filed 2020-11-05 | -$80.00K derived: sum of 3 quarters · filed 2020-11-05 | $120.00K 10-K · filed 2020-03-13 | |
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-05 | $100.00K derived: sum of 2 quarters · filed 2020-11-05 | $300.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $0.10 10-Q · filed 2020-08-05 | $0.20 10-Q · filed 2020-08-05 | |||
| 2018-12-31 | $120.00K 10-K · filed 2020-03-13 | $100.00K 10-K · filed 2019-03-13 | |||
| 2017-12-31 | $200.00K 10-K · filed 2019-03-13 | ||||
| 2017-03-31 | $48.00K 10-Q · filed 2017-05-12 | $104.00K derived: sum of 2 quarters · filed 2018-03-29 | $152.00K derived: sum of 3 quarters · filed 2018-03-29 | $223.89K derived: sum of 4 quarters · filed 2018-03-29 | |
| 2016-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $104.00K derived: sum of 2 quarters · filed 2018-03-29 | $175.89K derived: sum of 3 quarters · filed 2018-03-29 | $200.00K 10-K · filed 2018-03-29 | $192.00K 10-K · filed 2017-02-24 |
| 2016-09-30 | $48.00K 10-Q · filed 2016-11-10 | $119.89K derived: sum of 2 quarters · filed 2016-11-10 | $144.00K 10-Q · filed 2016-11-10 | $168.11K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2016-06-30 | $71.89K 10-Q · filed 2016-08-12 | $96.00K 10-Q · filed 2016-08-12 | $120.11K derived: sum of 3 quarters · filed 2017-05-12 | $144.22K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2016-03-31 | $24.11K 10-Q · filed 2017-05-12 | $48.22K derived: sum of 2 quarters · filed 2017-05-12 | $72.34K derived: sum of 3 quarters · filed 2017-05-12 | $96.45K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | $24.11K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $48.22K derived: sum of 2 quarters · filed 2017-02-24 | $72.34K derived: sum of 3 quarters · filed 2017-02-24 | $96.45K 10-K · filed 2017-02-24 | |
| 2015-09-30 | $24.11K 10-Q · filed 2016-11-10 | $48.22K derived: sum of 2 quarters · filed 2016-11-10 | $72.34K 10-Q · filed 2016-11-10 | $96.45K derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | $24.11K 10-Q · filed 2016-08-12 | $48.22K 10-Q · filed 2016-08-12 | $72.34K derived: sum of 3 quarters · filed 2016-08-12 | $96.45K derived: sum of 4 quarters · filed 2016-08-12 | |
| 2015-03-31 | $24.11K 10-Q · filed 2016-05-13 | $48.22K derived: sum of 2 quarters · filed 2016-05-13 | $72.34K derived: sum of 3 quarters · filed 2016-05-13 | $96.45K derived: sum of 4 quarters · filed 2016-05-13 | |
| 2014-12-31 | $24.11K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $48.22K derived: sum of 2 quarters · filed 2016-03-23 | $72.34K derived: sum of 3 quarters · filed 2016-03-23 | $96.45K 10-K · filed 2016-03-23 | |
| 2014-09-30 | $24.11K 10-Q · filed 2015-11-10 | $48.22K derived: sum of 2 quarters · filed 2015-11-10 | $72.34K 10-Q · filed 2015-11-10 | $96.45K derived: sum of 4 quarters · filed 2015-11-10 | |
| 2014-06-30 | $24.11K 10-Q · filed 2015-08-11 | $48.22K 10-Q · filed 2015-08-11 | $72.34K derived: sum of 3 quarters · filed 2015-08-11 | $96.45K derived: sum of 4 quarters · filed 2015-08-11 | |
| 2014-03-31 | $24.11K 10-Q · filed 2015-05-12 | $48.22K derived: sum of 2 quarters · filed 2015-05-12 | $72.34K derived: sum of 3 quarters · filed 2015-05-12 | $96.45K derived: sum of 4 quarters · filed 2015-05-12 | |
| 2013-12-31 | $24.11K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $48.22K derived: sum of 2 quarters · filed 2015-03-09 | $72.34K derived: sum of 3 quarters · filed 2015-03-09 | $96.45K 10-K · filed 2015-03-09 | |
| 2013-09-30 | $24.11K 10-Q · filed 2014-11-10 | $48.22K derived: sum of 2 quarters · filed 2014-11-10 | $72.34K 10-Q · filed 2014-11-10 | $96.45K derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | $24.11K 10-Q · filed 2014-08-11 | $48.22K 10-Q · filed 2014-08-11 | $72.34K derived: sum of 3 quarters · filed 2014-08-11 | $96.45K derived: sum of 4 quarters · filed 2014-08-11 | |
| 2013-03-31 | $24.11K 10-Q · filed 2014-05-12 | $48.22K derived: sum of 2 quarters · filed 2014-05-12 | $72.34K derived: sum of 3 quarters · filed 2014-05-12 | $96.45K derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $24.11K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $48.22K derived: sum of 2 quarters · filed 2014-03-28 | $72.34K derived: sum of 3 quarters · filed 2014-03-28 | $96.45K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $24.11K 10-Q · filed 2012-11-13 | $48.22K derived: sum of 2 quarters · filed 2012-11-13 | $72.34K 10-Q · filed 2013-11-12 | $96.45K derived: sum of 4 quarters · filed 2013-05-14 | |
| 2012-06-30 | $24.11K 10-Q · filed 2012-08-14 | $48.22K 10-Q · filed 2013-08-12 | $72.34K derived: sum of 3 quarters · filed 2013-05-14 | $96.45K derived: sum of 4 quarters · filed 2013-05-14 | |
| 2012-03-31 | $24.11K 10-Q · filed 2013-05-14 | $48.22K derived: sum of 2 quarters · filed 2013-05-14 | $72.34K derived: sum of 3 quarters · filed 2013-05-14 | $96.45K derived: sum of 4 quarters · filed 2013-05-14 | |
| 2011-12-31 | $24.11K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06 | $48.22K derived: sum of 2 quarters · filed 2013-03-06 | $72.34K derived: sum of 3 quarters · filed 2013-03-06 | $96.45K 10-K · filed 2013-03-06 | |
| 2011-09-30 | $24.11K 10-Q · filed 2012-11-13 | $48.22K derived: sum of 2 quarters · filed 2012-11-13 | $72.34K 10-Q · filed 2012-11-13 | ||
| 2011-06-30 | $24.11K 10-Q · filed 2012-08-14 | $48.22K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |